Economic Impact of Pancreatic Enzyme Replacement Therapy (PERT) in Pancreatic Cancer Patients Who May Have Exocrine Pancreatic Insufficiency (EPI) Following Pancreatic Surgery

被引:0
作者
Khandelwal, Nikhil [1 ]
Harb, Diala [1 ]
Manthena, Shivaji [1 ]
Reilly, Patrick [1 ]
Vora, Jamie [2 ]
Morris-Stiff, Gareth [3 ]
机构
[1] AbbVie Inc, Mettawa, IL USA
[2] AbbVie Inc, N Chicago, IL USA
[3] Cleveland Clin, Inst Digest Dis, Cleveland, OH 44106 USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
98
引用
收藏
页码:S53 / S54
页数:2
相关论文
共 50 条
  • [1] Economic Impact of Pancreatic Enzyme Replacement Therapy (PERT) in Pancreatic Cancer (PC) Patients Who May Have Exocrine Pancreatic Insufficiency (EPI) Following Pancreatic Surgery
    Khandelwal, N.
    Harb, D.
    Reilly, P.
    Manthena, S.
    Vora, J.
    Morris-Stiff, G.
    PANCREAS, 2018, 47 (10) : 1399 - 1400
  • [2] ECONOMIC IMPACT OF TREATMENT ADHERENCE IN EXOCRINE PANCREATIC INSUFFICIENCY (EPI) PATIENTS TREATED WITH PANCREATIC ENZYME REPLACEMENT THERAPY (PERT)
    Khandelwal, N.
    Wang, S.
    Johns, B.
    Vora, J.
    Castelli-Haley, J.
    Singh, V. K.
    VALUE IN HEALTH, 2018, 21 : S85 - S86
  • [3] Exocrine Insufficiency and Pancreatic Enzyme Replacement Therapy in Pancreatic Cancer
    Watson, L.
    CLINICAL ONCOLOGY, 2010, 22 (05) : 391 - 391
  • [4] EXOCRINE PANCREATIC INSUFFICIENCY (EPI) WORKUP AND PANCREATIC ENZYME REPLACEMENT THERAPY (PERT) ARE INCONSISTENTLY PROVIDED TO PATIENTS WITH RESECTABLE VS. METASTATIC PANCREATIC CANCER (PC)
    Dhandibhotla, Sharvani
    Liu, Yitong
    Bazerbachi, Fateh
    Weekes, Colin D.
    Fernandez-Del Castillo, Carlos
    Hernandez-Barco, Yasmin G.
    GASTROENTEROLOGY, 2023, 164 (06) : S849 - S850
  • [5] Analysis of Real World Patient Experience With Pancreatic Enzyme Replacement Therapy (PERT) in the Treatment of Exocrine Pancreatic Insufficiency (EPI)
    Barkin, Jodie A.
    Harb, Diala M.
    Kort, Jens M.
    Barkin, Jamie S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S19 - S20
  • [6] Pancreatic Exocrine Insufficiency as a Complication of Gastrointestinal Surgery and the Impact of Pancreatic Enzyme Replacement Therapy
    Chaudhary, Adarsh
    Enrique Dominguez-Munoz, J.
    Layer, Peter
    Lerch, Markus M.
    DIGESTIVE DISEASES, 2020, 38 (01) : 53 - 68
  • [7] ECONOMIC IMPACT OF PANCREATIC ENZYME REPLACEMENT THERAPY ADHERENCE IN CYSTIC FIBROSIS PATIENTS WITH EXOCRINE PANCREATIC INSUFFICIENCY
    Khandelwal, N.
    Wang, S.
    Vora, J.
    PEDIATRIC PULMONOLOGY, 2017, 52 : S453 - S453
  • [8] Analysis of Real-World Patient Experience With Pancreatic Enzyme Replacement Therapy (PERT) in the Treatment of Exocrine Pancreatic Insufficiency (EPI)
    Barkin, J. A.
    Harb, D.
    Kort, J.
    Barkin, J. S.
    PANCREAS, 2021, 50 (07) : 1046 - 1047
  • [9] Perioperative Exocrine Pancreatic Insufficiency and Pancreatic Enzyme Replacement Therapy
    Aleassa, Essa M.
    Morris-Stiff, Gareth
    JOURNAL OF THE PANCREAS, 2018, 19 (02): : 91 - 95
  • [10] Exocrine Pancreatic Insufficiency Following Gastric Resectional Surgery—is Routine Pancreatic Enzyme Replacement Therapy Necessary?
    Rajeevan Philip Sridhar
    Myla Yacob
    Sudipta Dhar Chowdhury
    Kunissery A. Balasubramanian
    Inian Samarasam
    Indian Journal of Surgical Oncology, 2021, 12 : 391 - 396